Mirvetuximab soravtansine 100mg/20ml solution for infusion vials
in short Mirvetuximab soravtansine 100mg/20ml inf vials
- SNOMED code
45391711000001105- Active compound
- Mirvetuximab soravtansine
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 20 ml, vial
- Ingredients
- Mirvetuximab soravtansine
— 5 mg
/ 1 ml
based on ingredient substance
- Form & Route
- solutioninfusion.intravenous
Solution for infusion, Intravenous - Controlled drug
- No Controlled Drug Status
Products
Elahere 100mg/20ml concentrate for solution for infusion vials (AbbVie Ltd)
in short Elahere 100mg/20ml concentrate for inf vials
Elahere 100mg/20ml concentrate for solution for infusion vials
- SNOMED code
45358711000001105- Supplier
- AbbVie Ltd
- Licensed as
- Medicines - MHRA/EMA
- EMA (European Medicines Agency) Monitoring
- ▼ Yes, black triangle marked
- Availability restrictions
- None
- Licensed route
- Intravenous
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Elahere 100mg/20ml concentrate for solution for infusion vials (AbbVie Ltd) 1 vial45358811000001102 ref. pack | 💯 Available Legal category: POM | 08054083029320 | NHS Indicative Price £4,950 | • Hospital |
| — |
Reference packs
Mirvetuximab soravtansine 100mg/20ml solution for infusion vials 1 vial
- SNOMED code
45358611000001101- Quantity and unit
- 1 vial
- Packs